Related Experiment Video
Updated: Jan 26, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
CBP/p300 antagonises EGFR-Ras-Erk signalling and suppresses increased Ras-Erk signalling-induced tumour formation in
Taeko Ichise1,2, Nobuaki Yoshida1, Hirotake Ichise1,2
1Laboratory of Developmental Genetics, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Abstract:
CREB-binding protein (CBP) and p300 have oncogenic properties; both co-operate with pro-oncogenic transcription factors downstream of Ras-Erk signalling to support cell proliferation. By contrast, missense, truncating and in-frame mutations of CBP/p300 are found frequently in some human cancers, including cutaneous squamous cell carcinomas that originate from epidermal keratinocytes. Data support that dysfunction of CBP/p300 contributes to keratinocyte hyperproliferation and tumourigenesis; however, the mechanism by which dysfunction of CBP/p300 affects keratinocytes is unknown. Here, we used mice harbouring keratinocyte-specific genetic modifications to examine the role of CBP/p300 in the epidermis. While a single copy of either Crebbp or Ep300 was necessary and sufficient for maintaining epidermal development, reduced expression of CBP/p300 strengthened the Ras-Erk signalling-induced hyperplastic phenotype of epidermal keratinocytes. Reduced CBP/p300 expression increased ligand-induced EGFR activity while decreasing basal expression of Mig6, a negative regulator of EGFR. A reduction in CBP/p300, in combination with increased Ras-Erk signalling, also promoted epidermal tumour formation in mice. Thus, our findings support that CBP/p300 acts as a tumour suppressor in epidermal keratinocytes by counteracting EGFR-Ras-Erk signalling. © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Insights
CREB-binding protein (CBP) and p300 function as tumor suppressors in skin cells. Reduced CBP/p300 levels promote skin cancer by enhancing EGFR-Ras-Erk signaling pathways.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- CREB-binding protein (CBP) and p300 are known to possess oncogenic properties by cooperating with pro-oncogenic transcription factors.
- Mutations in CBP/p300 are frequently observed in human cancers, including cutaneous squamous cell carcinomas.
- The precise mechanism by which CBP/p300 dysfunction contributes to keratinocyte hyperproliferation and tumorigenesis remains unclear.
Purpose of the Study:
- To investigate the role of CBP/p300 in epidermal development and function using keratinocyte-specific genetic models in mice.
- To elucidate the molecular mechanisms underlying CBP/p300's influence on keratinocyte proliferation and tumor formation.
Main Methods:
- Utilized mice with keratinocyte-specific genetic modifications to study CBP/p300 function.
- Analyzed the impact of reduced CBP/p300 expression on Ras-Erk signaling, EGFR activity, and Mig6 expression.
- Assessed the combined effect of reduced CBP/p300 and enhanced Ras-Erk signaling on epidermal tumor development.
Main Results:
- A single copy of Crebbp or Ep300 was sufficient for normal epidermal development.
- Reduced CBP/p300 expression exacerbated Ras-Erk signaling-induced keratinocyte hyperproliferation.
- Decreased CBP/p300 levels led to increased EGFR activity and reduced Mig6 expression, promoting epidermal tumor formation in conjunction with heightened Ras-Erk signaling.
Conclusions:
- CBP/p300 acts as a tumor suppressor in epidermal keratinocytes.
- CBP/p300 counteracts oncogenic EGFR-Ras-Erk signaling pathways in the skin.
- Dysfunction of CBP/p300 contributes to skin cancer development by disrupting EGFR regulation.
More Related Videos
Related Concept Videos
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Bacterial Signaling
What is Cell Signaling?
Endocrine Signaling
Paracrine Signaling

